US2020384198A1PendingUtilityA1

Methods and Systems for Modifying Bioactive Agent Use

Assignee: THE INVENT SCIENCE FUND I LLCPriority: Apr 24, 2008Filed: Aug 6, 2020Published: Dec 10, 2020
Est. expiryApr 24, 2028(~1.7 yrs left)· nominal 20-yr term from priority
A61B 5/24A61M 2230/10A61M 2230/30A61B 5/08A61B 5/416A61M 2205/50A61B 5/05A61B 5/16G16H 40/20A61B 5/4266G06F 16/24575A61B 5/418G16H 20/10A61B 5/415A61M 5/1723A61B 5/4839A61B 5/024A61M 2230/04A61M 2205/52A61B 5/411A61M 2230/65G06F 3/011A61M 2205/581A61M 2205/502A61B 5/48A61B 5/04
70
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods, computer program products, and systems are described that include measuring at least one effect of a combined bioactive agent and artificial sensory experience on an individual and/or modifying at least one of the bioactive agent or the artificial sensory experience at least partially based on the at least one effect.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A system comprising:
 a display;   data processing hardware; and   memory hardware in communication with the data processing hardware, the memory storing instructions that when executed on the data processing hardware cause the data processing hardware to perform operations comprising:
 accepting at least one mental diagnosis associated with an individual; 
 searching at least one database at least partly based on the at least one mental diagnosis; 
 selecting, from the at least one database, at least one artificial sensory experience for use in combination with at least one prescription medication to at least partially address the at least one mental diagnosis associated with the individual; 
 implementing, via at least the display, the at least one artificial sensory experience to at least partially address the at least one mental diagnosis associated with the individual; 
 measuring at least one effect of the artificial sensory experience and the prescription medication; and 
 modifying at least one of the artificial sensory experience and the prescription medication at least partially based on the at least one effect, comprising:
 modifying a prescription medication dosage of the at least one prescription medication; and 
 transmitting a modified prescription medication dosage signal based on the modified prescription medication dosage to an administration unit configured to administer the modified prescription medication dosage to the individual. 
 
   
     
     
         2 . The system of  claim 1 , wherein the at least one mental diagnosis comprises schizophrenia. 
     
     
         3 . The system of  claim 2 , wherein the at least one prescription medication comprises an antipsychotic. 
     
     
         4 . The system of  claim 1 , wherein the at least one mental diagnosis comprises post-traumatic stress disorder. 
     
     
         5 . The system of  claim 4 , wherein the at least one prescription medication comprises an anxiolytic. 
     
     
         6 . The system of  claim 1 , wherein the at least one mental diagnosis comprises depression. 
     
     
         7 . The system of  claim 6 , wherein the at least one prescription medication comprises an antidepressant. 
     
     
         8 . The system of  claim 1 , wherein the at least one mental diagnosis comprises bipolar disorder. 
     
     
         9 . The system of  claim 8 , wherein the at least one prescription medication comprises at least one of an antipsychotic, an antidepressant, a mood stabilizer, a hypnotic, or a sleeping agent. 
     
     
         10 . The system of  claim 1 , wherein the at least one mental diagnosis comprises a developmental disorder. 
     
     
         11 . A method comprising:
 accepting, via one or more processors, at least one mental diagnosis associated with an individual;   searching, via the one or more processors, at least one database at least partly based on the at least one mental diagnosis;   selecting, via the one or more processors, from the at least one database, at least one artificial sensory experience for use in combination with at least one prescription medication to at least partially address the at least one mental diagnosis associated with the individual;   implementing, via at least a display in communication with the one or more processors, the at least one artificial sensory experience to at least partially address the at least one mental diagnosis associated with the individual;   measuring, via the one or more processors, at least one effect of the artificial sensory experience and the prescription medication; and   modifying, via the one or more processors, at least one of the artificial sensory experience and the prescription medication at least partially based on the at least one effect, comprising:
 modifying, via the one or more processors, a prescription medication dosage of the at least one prescription medication; and 
 transmitting, via the one or more processors, a modified prescription medication dosage signal based on the modified prescription medication dosage to an administration unit configured to administer the modified prescription medication dosage to the individual. 
   
     
     
         12 . The method of  claim 11 , wherein the at least one mental diagnosis comprises schizophrenia. 
     
     
         13 . The method of  claim 12 , wherein the at least one prescription medication comprises an antipsychotic. 
     
     
         14 . The method of  claim 11 , wherein the at least one mental diagnosis comprises post-traumatic stress disorder. 
     
     
         15 . The method of  claim 14 , wherein the at least one prescription medication comprises an anxiolytic. 
     
     
         16 . The method of  claim 11 , wherein the at least one mental diagnosis comprises depression. 
     
     
         17 . The method of  claim 16 , wherein the at least one prescription medication comprises an antidepressant. 
     
     
         18 . The method of  claim 11 , wherein the at least one mental diagnosis comprises bipolar disorder. 
     
     
         19 . The method of  claim 18 , wherein the at least one prescription medication comprises at least one of an antipsychotic, an antidepressant, a mood stabilizer, a hypnotic, or a sleeping agent. 
     
     
         20 . The method of  claim 11 , wherein the at least one mental diagnosis comprises a developmental disorder.

Join the waitlist — get patent alerts

Track US2020384198A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.